Xuan-xuan Dai
Wenzhou, 325015, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Momordin Ic targets SREBP1 to disrupt lipid homeostasis and trigger synergistic apoptosis-ferroptosis in triple-negative breast cancer.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 26, 2025
Cyclovirobuxine D inhibits triple-negative breast cancer via YAP/TAZ suppression and activation of the FOXO3a/PINK1-Parkin pathway-induced mitophagy.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 07, 2024
Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer.
Journal: OncoTargets and therapy
Published: November 30, 2016
Co-expression networks revealed potential core lncRNAs in the triple-negative breast cancer.
Journal: Gene
Published: March 19, 2016
Severe thrombocytopenia induced by second exposure to trastuzumab can be alleviated by prolonging the interval between treatments.
Journal: Clinical breast cancer
Published: October 04, 2013
Preoperative BRAF mutation is predictive of occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: July 18, 2012
Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas.
Journal: Medical oncology (Northwood, London, England)
Published: July 06, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026